Lino DA SILVA FERREIRA profile

Lino Ferreira is Investigator Coordinator (equivalent to Full Professor) at the Faculty of Medicine at the University of Coimbra and affiliated with the Center of Neurosciences and Cell Biology (CNC) a research unit at the same University. In the last 5 years, the lab has contributed for two main avenues of research: (i) disease modeling and drug screening program based on (aged) tissue models from human stem cells and (ii) therapies based on nanomedicine platforms. The lab has done significant contributions at the interface of engineering with biology, in particular, in the development of advanced nanoformulations for medical applications (https://doi.org/10.1002/anie.201911398; https://doi.org/10.1021/acsnano.7b07538; https://doi.org/10.1038/ncomms15204), tissue models for screening and disease modeling (https://doi.org/10.1073/pnas.1617451114; https://doi.org/10.1038/s41467-017-00746-7), particularly in the area of ageing (https://doi.org/10.1038/s41467-020-17901-2) and in the use of extracellular vesicles as delivery systems (https://doi.org/10.1002/jev2.12111; https://doi.org/10.1021/acsnano.9b00376). In the last 5 years, he attracted 7.45 million euros of competitive funding including 1 ERA Chair project, 1 Twinning project, 1 Marie Curie ITN project, 5 Marie Curie International fellowships as well as several FCT and industry projects. In the last 5 years, he has published 63 articles in international peer-reviewed journals and 4 book chapters and he has disseminated his work in more than 50 international conferences. Since the beginning of his career he gathered more than 13500 citations by peers, endowing him an h-index of 59. Members of his group have founded companies (e.g. Tissium, Exogenus Therapeutics, Matera, Curemat) that attracted more than 50M ¿ in venture capital. He is the inventor of more than 22 international patents (10 licensed to companies). He has successfully supervised 20 PhD students (11 in the last 5 years) and 15 post-docs (5 in the last 5 years).

Biomaterials, Stem cells, Gene editing, Anti-ageing formulations

ORCID: 0000-0001-8985-9302